Investing
Bristol Myers wins dismissal of lawsuit over Celgene drugs
© Reuters. FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder
NEW YORK (Reuters) – A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers (NYSE:) Squibb Co of defrauding investors who stood to receive $6.4 billion had it won federal approval by specified deadlines for drugs developed by the former Celgene Corp (NASDAQ:).
Read the full article here
-
Make Money7 days ago
4 Tips to Grow a Side Hustle While Working Full Time (and Have a Life)
-
Passive Income7 days ago
How to Ensure AI Is Being Used Ethically in Your Business
-
Side Hustles5 days ago
NHTSA Investigates Tesla Full Self-Driving Feature
-
Investing5 days ago
Taiwan Semi to generate $110 billion in 2025 revenue: Needham By Investing.com
-
Investing5 days ago
Teen Brothers’ $1.2M Business Began as Facebook Side Hustle
-
Side Hustles5 days ago
3 Ways Data Can Drive Sustainable Decision-Making in Business
-
Personal Finance5 days ago
A growing share of Gen Z adults don't think they'll retire: only 20% are saving for it
-
Make Money6 days ago
4 Ways to Get $10 in Sam’s Club Cash for Free This Week